Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marla-C Dubinsky

Showing results (171-180 of 247) with videos related to

Pageof 25
Sort By:
Current Medical Research and Opinion|July 10, 2025
Impact of moderate-to-severe ulcerative colitis and Crohn's disease on sexual activity: United States and European patient perspectives from the communicating needs and features of IBD experiences (CONFIDE) surveyMarla C Dubinsky, Alison Potts Bleakman, Stefan Schreiber, et al.
Inflammatory Bowel Diseases|October 12, 2004
A pilot study of adalimumab in infliximab-allergic patientsAdrienne Youdim, Eric A Vasiliauskas, Stephan R Targan, et al.
Inflammatory Bowel Diseases|September 26, 2025
Long-Term Ozanimod Therapy in Patients With Moderately Active Ulcerative Colitis After Failure of 5-Aminosalicylic AcidAndres Yarur, Peter Irving, Britta Siegmund, et al.
Crohn'S & Colitis 360|February 13, 2023
Impact of Bowel Urgency on Quality of Life and Clinical Outcomes in Patients With Ulcerative ColitisMarla C Dubinsky, Remo Panaccione, James D Lewis, et al.
Crohn'S & Colitis 360|February 13, 2023
Methodology and Initial Results From a Real-World Observational Cohort of Patients With Inflammatory Bowel Disease: TARGET-IBDBenjamin Click, Edward L Barnes, Benjamin L Cohen, et al.
Inflammatory Bowel Diseases|April 23, 2016
TNFRSF1B Is Associated with ANCA in IBDDalin Li, Mark S Silverberg, Talin Haritunians, et al.
Inflammatory Bowel Diseases|March 11, 2011
Combination of genetic and quantitative serological immune markers are associated with complicated Crohn's disease behaviorGary R Lichtenstein, Stephan R Targan, Marla C Dubinsky, et al.
Journal of Crohn'S & Colitis|May 16, 2019
Higher Trough Vedolizumab Concentrations During Maintenance Therapy are Associated With Corticosteroid-Free Remission in Inflammatory Bowel DiseaseRyan C Ungaro, Andres Yarur, Jacqueline Jossen, et al.
Inflammatory Bowel Diseases|January 4, 2019
Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative ColitisMatthew C Choy, Dean Seah, David M Faleck, et al.
Alimentary Pharmacology & Therapeutics|July 26, 2024
Efficacy and safety of risankizumab by baseline corticosteroid use and achievement of corticosteroid-free clinical and endoscopic outcomes in patients with moderately to severely active Crohn's diseaseStefan Schreiber, Raymond K Cross, Remo Panaccione, et al.
Pageof 25

Showing results (171-180 of 247) with videos related to

Sort By:
Pageof 25
Current Medical Research and Opinion|July 10, 2025
Impact of moderate-to-severe ulcerative colitis and Crohn's disease on sexual activity: United States and European patient perspectives from the communicating needs and features of IBD experiences (CONFIDE) surveyMarla C Dubinsky, Alison Potts Bleakman, Stefan Schreiber, et al.
Inflammatory Bowel Diseases|October 12, 2004
A pilot study of adalimumab in infliximab-allergic patientsAdrienne Youdim, Eric A Vasiliauskas, Stephan R Targan, et al.
Inflammatory Bowel Diseases|September 26, 2025
Long-Term Ozanimod Therapy in Patients With Moderately Active Ulcerative Colitis After Failure of 5-Aminosalicylic AcidAndres Yarur, Peter Irving, Britta Siegmund, et al.
Crohn'S & Colitis 360|February 13, 2023
Impact of Bowel Urgency on Quality of Life and Clinical Outcomes in Patients With Ulcerative ColitisMarla C Dubinsky, Remo Panaccione, James D Lewis, et al.
Crohn'S & Colitis 360|February 13, 2023
Methodology and Initial Results From a Real-World Observational Cohort of Patients With Inflammatory Bowel Disease: TARGET-IBDBenjamin Click, Edward L Barnes, Benjamin L Cohen, et al.
Inflammatory Bowel Diseases|April 23, 2016
TNFRSF1B Is Associated with ANCA in IBDDalin Li, Mark S Silverberg, Talin Haritunians, et al.
Inflammatory Bowel Diseases|March 11, 2011
Combination of genetic and quantitative serological immune markers are associated with complicated Crohn's disease behaviorGary R Lichtenstein, Stephan R Targan, Marla C Dubinsky, et al.
Journal of Crohn'S & Colitis|May 16, 2019
Higher Trough Vedolizumab Concentrations During Maintenance Therapy are Associated With Corticosteroid-Free Remission in Inflammatory Bowel DiseaseRyan C Ungaro, Andres Yarur, Jacqueline Jossen, et al.
Inflammatory Bowel Diseases|January 4, 2019
Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative ColitisMatthew C Choy, Dean Seah, David M Faleck, et al.
Alimentary Pharmacology & Therapeutics|July 26, 2024
Efficacy and safety of risankizumab by baseline corticosteroid use and achievement of corticosteroid-free clinical and endoscopic outcomes in patients with moderately to severely active Crohn's diseaseStefan Schreiber, Raymond K Cross, Remo Panaccione, et al.
Pageof 25